Proton pump inhibitors decrease stomach acid to treat GERD and stomach ulcers. Many require a prescription, but you can purchase some over the counter. Overuse can lead to severe side effects like ...
Please provide your email address to receive an email when new articles are posted on . Proton pump inhibitors may be associated with pharmacovigilance signals for ...
Proton Pump Inhibitors (PPIs) Market Worth USD 3.24 Billion, at 4% CAGR During 2019-2023 | Technavio
LONDON--(BUSINESS WIRE)--According to Technavio Research Report "Proton Pump Inhibitors (PPIs) Market by product (OTC PPIs and prescription PPIs) and geographical regions (North America, Europe, Asia ...
TOKYO, Jun 2, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today the launch of "Pariet S" (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn ...
Xuanzhu Biopharmaceutical Co. Ltd., a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd., received marketing approval in mainland China for its anaprozole sodium enteric-coated tablet as a ...
The "Antacid Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Dosage Form (Tablet, Liquid, Others); Drug Class (Proton pump inhibitors, H2 Antagonist, Acid neutralizers); Distribution ...
The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results